Key | % Net Assets |
---|---|
GlaxoSmithKline | 6.4% |
Royal Dutch Shell | 5.8% |
BP | 5.5% |
HSBC | 4.6% |
Other | 77.7% |
Name | % Net Assets |
---|---|
GlaxoSmithKline | 6.4% |
Royal Dutch Shell | 5.8% |
BP | 5.5% |
HSBC | 4.6% |
UBM | 4.1% |
Tyman plc | 3.8% |
Reed Elsevier | 3.7% |
Vodafone | 3.3% |
Henry Boot | 3.1% |
FirstGroup | 2.9% |
Key | % Net Assets |
---|---|
Financials | 19.50% |
Industrials | 19.30% |
Oil & Gas | 16.20% |
Consumer Services | 15.10% |
Health Care | 11.70% |
Date | 02-May-2024 |
---|---|
NAV | 8,214.66p |
Currency | GBP |
Change | -11.38p |
% | -0.14% |
YTD change | 264.34p |
YTD % | 3.32% |
Fund Inception | 20/06/2002 |
---|---|
Fund Manager | Matthew Tillett |
TER | 1.43 (31-Aug-2013) |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | £500 |
Savings | £50 |
Charges | |
---|---|
Initial | 4.00% |
Annual Mang't | 1.25% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.06 |
You are here: research